1. A phase I/II trial of iodine-131–tositumomab (anti-CD20), etoposide, cyclophosphamide, and autologous stem cell transplantation for relapsed B-cell lymphomas by Oliver W. Press, Janet F. Eary, Ted Gooley, Ajay K. Gopal, Stephen Liu, Joseph G. Rajendran, David G. Maloney, Stephen Petersdorf, Sharon A. Bush, Lawrence D. Durack, Paul J. Martin, Darrell R. Fisher, Brent Wood, James W. Borrow, Bruce Porter, Justin P. Smith, Dana C. Matthews, Frederick R. Appelbaum, and Irwin D. Bernstein Blood Volume 96(9):2934-2942 November 1, 2000 ©2000 by American Society of Hematology

2. Overall survival of patients with relapsed B-cell lymphomas with 2 treatments.Fifty-two patients were treated with 131I-tositumomab, etoposide, cyclophosphamide, and autologous stem-cell transplantation (ASCT) (thin line), and 105 patients were treated with... Oliver W. Press et al. Blood 2000;96:2934-2942 ©2000 by American Society of Hematology

3. Progression-free survival in patients with relapsed B-cell lymphomas.Fifty-two patients were treated with 131I-tositumomab, etoposide, cyclophosphamide, and ASCT (thin line), and 105 patients were treated with external-beam TBI (1.5 Gy twice a day for 4 day... Oliver W. Press et al. Blood 2000;96:2934-2942 ©2000 by American Society of Hematology

4. Survival analyses according to type of lymphoma.(A) Overall survival in 38 patients with relapsed indolent lymphomas (thin solid line) and 14 patients with relapsed aggressive lymphomas (short dashes) treated with 131I-tositumomab, etoposide, cyclophosphami... Oliver W. Press et al. Blood 2000;96:2934-2942 ©2000 by American Society of Hematology

5. Landmark analyses of bone marrow and blood.Solid symbols indicate presence of a clonal marker indicative of lymphoma; open symbols indicate absence of clonal markers. Oliver W. Press et al. Blood 2000;96:2934-2942 ©2000 by American Society of Hematology

6. Landmark analyses in the 42 patients with serial cytogenetic assessments of bone marrow samples.Normal cytogenetic findings, ■; abnormal results, ▪. Oliver W. Press et al. Blood 2000;96:2934-2942 ©2000 by American Society of Hematology